SE8605295D0 - Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes - Google Patents

Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes

Info

Publication number
SE8605295D0
SE8605295D0 SE8605295A SE8605295A SE8605295D0 SE 8605295 D0 SE8605295 D0 SE 8605295D0 SE 8605295 A SE8605295 A SE 8605295A SE 8605295 A SE8605295 A SE 8605295A SE 8605295 D0 SE8605295 D0 SE 8605295D0
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
crossprotective
reactive
cell lines
antibodies
Prior art date
Application number
SE8605295A
Other languages
English (en)
Other versions
SE468831B (sv
SE8605295L (sv
Inventor
A W Siadak
M J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8605295D0 publication Critical patent/SE8605295D0/sv
Publication of SE8605295L publication Critical patent/SE8605295L/sv
Publication of SE468831B publication Critical patent/SE468831B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8605295A 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer SE468831B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (3)

Publication Number Publication Date
SE8605295D0 true SE8605295D0 (sv) 1986-12-10
SE8605295L SE8605295L (sv) 1987-06-11
SE468831B SE468831B (sv) 1993-03-29

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605295A SE468831B (sv) 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer

Country Status (21)

Country Link
US (4) US5378812A (sv)
JP (1) JPH07116237B2 (sv)
KR (1) KR910008361B1 (sv)
CN (1) CN86108380A (sv)
AT (1) AT400441B (sv)
BE (1) BE905890A (sv)
CH (1) CH677362A5 (sv)
DE (1) DE3642095C2 (sv)
DK (1) DK594586A (sv)
FI (1) FI86377C (sv)
FR (1) FR2593826B1 (sv)
GB (1) GB2185266B (sv)
HU (1) HUT41836A (sv)
IE (1) IE59741B1 (sv)
IT (1) IT1199735B (sv)
LU (1) LU86711A1 (sv)
NL (1) NL8603132A (sv)
NO (1) NO178718C (sv)
NZ (1) NZ218499A (sv)
PT (1) PT83894B (sv)
SE (1) SE468831B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
WO1990011350A1 (fr) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
DE3786173T2 (de) * 1986-12-15 1993-12-16 Mitsui Toatsu Chemicals Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten.
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
WO1990013660A2 (en) * 1989-05-09 1990-11-15 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
EP1576181B1 (en) * 2002-01-31 2013-08-14 Systagenix Wound Management IP Co. BV. Method for detecting pathogenic bacteria in wounds
US20060292562A1 (en) * 2002-05-29 2006-12-28 Pollard Harvey B Methods of identifying genomic and proteomic biomarkers for cystic fibrosis, arrays comprising the biomarkers and methods of using the arrays
JP5271475B2 (ja) * 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
AU2004225575B2 (en) * 2003-01-31 2008-02-21 Ethicon, Inc. Method for detecting escherichia coli
CA2557612C (en) 2003-11-03 2014-06-17 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
CA2649663C (en) * 2006-05-01 2017-03-14 Bioness Neuromodulation Ltd. Improved functional electrical stimulation systems
CA2751433A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US20130022604A1 (en) * 2010-02-18 2013-01-24 Symphogen A/S Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
EP0233289B1 (en) * 1984-12-26 1993-03-10 Teijin Limited Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
NO864971L (no) 1987-06-11
FI86377B (fi) 1992-05-15
GB2185266B (en) 1990-09-05
SE468831B (sv) 1993-03-29
KR870005648A (ko) 1987-07-06
DK594586D0 (da) 1986-12-10
US5628996A (en) 1997-05-13
HUT41836A (en) 1987-05-28
IT1199735B (it) 1988-12-30
GB8629540D0 (en) 1987-01-21
US5662905A (en) 1997-09-02
NL8603132A (nl) 1987-07-01
CH677362A5 (sv) 1991-05-15
ATA328286A (de) 1995-05-15
GB2185266A (en) 1987-07-15
LU86711A1 (fr) 1988-07-14
FI865027A0 (fi) 1986-12-10
DE3642095C2 (de) 1998-10-01
IT8622630A0 (it) 1986-12-10
FR2593826B1 (fr) 1990-11-16
CN86108380A (zh) 1987-10-28
IE863230L (en) 1987-06-10
NO178718B (no) 1996-02-12
FI865027A (fi) 1987-06-11
PT83894A (en) 1987-01-01
BE905890A (fr) 1987-06-10
FR2593826A1 (fr) 1987-08-07
NO864971D0 (no) 1986-12-10
JPS62187417A (ja) 1987-08-15
US5378812A (en) 1995-01-03
JPH07116237B2 (ja) 1995-12-13
IE59741B1 (en) 1994-03-23
PT83894B (pt) 1989-07-31
NZ218499A (en) 1990-04-26
SE8605295L (sv) 1987-06-11
DK594586A (da) 1987-06-11
DE3642095A1 (de) 1987-07-02
US5627067A (en) 1997-05-06
KR910008361B1 (ko) 1991-10-12
NO178718C (no) 1996-05-22
AT400441B (de) 1995-12-27
FI86377C (sv) 1992-08-25

Similar Documents

Publication Publication Date Title
SE8605295D0 (sv) Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes
DK233385A (da) Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet
SE8700467D0 (sv) Cross-protective human monoclonal antibody compositions
CA2017025A1 (en) Tumor necrosis factor binding protein ii, its purification and antibodies thereto
NO962346L (no) Humaniserte antistoffer og anvendelser derav
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DK0670735T3 (da) Perifisering af hæmotopoietiske stamceller.
MY111682A (en) Altered antibodies and their preparations.
CA2093667A1 (en) Mouse monoclonal antibodies and uses thereof
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
IE861494L (en) Protective human monoclonal antibodies to pseudomonas¹aeruginosa exotoxin a
WO1990013660A3 (en) Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
CA2088370A1 (en) New use of monoclonal antibody
NO941347L (no) Fremgangsmåte for fremstilling av et humant monoklonalt antistoff
GEP20043233B (en) Composition Containing Blocking Monoclonal Antibody VLA-1

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8605295-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8605295-8

Format of ref document f/p: F